1. Safety and efficacy of subtotal or total parathyroidectomy for patients with secondary or tertiary hyperparathyroidism in four academic centers in the Netherlands
- Author
-
van der Plas, W.Y. (Willemijn Y.), Dulfer, R.R. (Roderick), Koh, E.Y. (Ezra Y.), Vogt, L. (Liffert), Appelman-Dijkstra, N.M. (Natasha), Schepers, A. (Abbey), Rotmans, J.I. (Joris), Pol, R.A. (Robert A.), Ginhoven, T.M. (Tessa) van, Hoorn, E.J. (Ewout), Nieveen Van Dijkum, E.J.M. (Els), Engelsman, A.F. (Anton F.), de Borst, M.H. (Martin H.), Kruijff, S. (Schelto), van der Plas, W.Y. (Willemijn Y.), Dulfer, R.R. (Roderick), Koh, E.Y. (Ezra Y.), Vogt, L. (Liffert), Appelman-Dijkstra, N.M. (Natasha), Schepers, A. (Abbey), Rotmans, J.I. (Joris), Pol, R.A. (Robert A.), Ginhoven, T.M. (Tessa) van, Hoorn, E.J. (Ewout), Nieveen Van Dijkum, E.J.M. (Els), Engelsman, A.F. (Anton F.), de Borst, M.H. (Martin H.), and Kruijff, S. (Schelto)
- Abstract
Purpose: Hyperparathyroidism (HPT) is a common abnormality in patients with end-stage renal disease (ESRD). Since the introduction of cinacalcet in 2004, a shift from surgery toward predominantly medical treatment has occurred. Surgery is thought to be associated with more complications than oral medication. The aim of this retrospective study was to evaluate 30-day outcomes and effectiveness of parathyroidectomy (PTx) in ESRD patients in the Netherlands. Methods: A national database containing data from four academic medical centers in the Netherlands of patients with ESRD-related HPT, who had undergone PTx and kidney transplantation between 1994
- Published
- 2018
- Full Text
- View/download PDF